Results from David Fish's Dividend Champions Index compiled as of July 30, 2013 projecting price upside results one year hence showed HCP, Inc. (HCP), the healthcare properties real estate investment trust, posted a 9.45% upside to lead a pack of just four dogs this month.
The chart above used one year mean target price set by brokerage analysts multiplied by the number of shares in a $1k investment to compare four Champions Index stocks showing the highest upside price potential into 2014 out of 20 selected by yield. The number of analysts providing price estimates was noted after the name for each stock. Three to nine analysts were considered optimal for a valid mean target price estimate.
This article reported results for the Champions Index as one of fourteen in a series of index-specific articles devoted to dividend yield and price upside results. Prompted by Seeking Alpha reader requests, the series has supplied results for these stock indices: Dow 30; Barron's 15 Gems; Russell 2000; S&P 500; S&P Aristocrats; Russell 1000; NASDAQ 100; NYSE International 100; Mergent Dividend Achievers; Champions; Contenders; Challengers; Carnevale's Power 25; Carnevale's Super 29.
Strategic Hotels & Resorts, Inc. (SHR), incorporated on January 27, 2004, operates as a self-administered and self-managed real estate investment trust (REIT). As of December 31, 2012, the Company�� portfolio included 18 full-service hotel interests located in urban and resort markets in the United States; Punta Mita, Nayarit, Mexico; Hamburg, Germany, and London, England. SHR conducts its operations through its direct and indirect subsidiaries, including its operating partnership, Strategic Hotel Funding, L.L.C. (SH Funding), which holds all of the Company�� assets. SHR is the sole managing member of SH Funding and held approximately 99% of its membership units as of February 27, 2013. SHR manages all business aspects of SH Funding, including the sale and purchase of hotels, the investment in these hotels and the financing of SH Funding and its assets. In September 2012, it acquired the JW Marriott Essex House Hotel in New York City. In October 2013, the Company announced that it has sold the Lakeshore Athletic Club property adjacent to the Fairmont Chicago hotel.
As of December 31, 2012, SH Funding owned interests in or leased 18 hotels, which included Fairmont Chicago, Fairmont Scottsdale Princess, Four Seasons Jackson Hole, Four Seasons Punta Mita Resort, Four Seasons Silicon Valley, Four Seasons Washington, D.C., Hotel del Coronado, Hyatt Regency La Jolla, InterContinental Chicago, InterContinental Miami, JW Marriott Essex House Hotel, Loews Santa Monica Beach Hotel, Marriott Hamburg, Marriott Lincolnshire Resort, Marriott London Grosvenor Square, Ritz-Carlton Half Moon Bay, Ritz-Carlton Laguna Niguel and Westin St. Francis.
The Hotel del Coronado is operated by a specialty management company, KSL Resorts. As of February 27, 2013, the Company wholly owned or leased 14 hotels, had a 53.5% and 51.0% interest in an affiliate that owned a hotel where it asset managed such hotel, and had 50.0% and 36.4% interests in, and acted as asset manager for, two affiliates that eac! h owned one hotel, and owned land held for development, including 20.5 acres of oceanfront land adjacent to its Four Seasons Punta Mita Resort, Nayarit, Mexico and 60 acres of oceanfront land near the Four Seasons Punta Mita Resort; a 20,000 square-foot parcel of land on the ocean in Santa Monica, California adjacent to its Loews Santa Monica Beach Hotel entitled for development and residential units; a 50% interest in an affiliate that owned 10 acres of land adjacent to the Fairmont Scottsdale Princess hotel, and a 31% interest in an affiliate with two parties that was developing the fractional ownership program known as the Four Seasons Residence Club Punta Mita.
Advisors' Opinion: - [By Anders Bylund]
Strategic Hotels & Resorts (NYSE: BEE ) raised its takeover defenses in 2008 in order to ward off opportunistic raiders amid general market turmoil. The REIT, which specializes in high-end hotels, extended its poison pill last year as the "lingering economic uncertainty" never went away. Six months later, in May 2013, the extension was cut short. No real explanation, but you could take this action as a vote of confidence in an improving economy. The stock has gained 14% in the seven months since, just ahead of the S&P's 11% improvement. No takeover bids here.
Hot Managed Healthcare Stocks To Own For 2015: Viasystems Group Inc.(VIAS)
Viasystems Group, Inc. provides multi-layer printed circuit boards (PCBs) and electro-mechanical solutions worldwide. The company?s products and services are used in a range of applications, including, automotive engine controls, data networking equipment, telecommunications switching equipment, complex medical, technical and industrial instruments, and flight control systems. Its PCBs products include circuitry and mounting surfaces to interconnect discrete electronic components, such as integrated circuits, capacitors, and resistors. The company?s electro-mechanical solutions comprise assembly of backplanes, assembly of printed circuit boards, fabrication of custom and standard metal enclosures, cabinets, racks, sub-racks and bus bars; systems integration; final assembly; and product testing and fulfillment. It also offers various manufacturing services consisting of design and prototyping, PCB and backpanel fabrication, backpanel assembly, PCB assembly, custom metal e nclosure fabrication, full system assembly and test, packaging and global distribution, after-sales support, and supply chain management. The company markets its products and services to original equipment manufacturers and contract electronic manufacturers in automotive, industrial and instrumentation, telecommunications, computer and data communications, and military and aerospace markets through its own sales and marketing organization, and through relationships with independent sales agents. The company was formerly known as Circo Technologies, Inc. and changed its name to Viasystems Group, Inc. in January 1997. Viasystems Group, Inc. was founded in 1996 and is headquartered in St. Louis, Missouri.
Advisors' Opinion: - [By Luke Jacobi]
Shares of Viasystems Group (NASDAQ: VIAS) got a boost, shooting up 35 percent to $15.80 after TTM Technologies (NASDAQ: TTMI) announced its plans to buy Viasystems for a total value of $16.46 per share.
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Viasystems Group (Nasdaq: VIAS ) , whose recent revenue and earnings are plotted below.
Hot Managed Healthcare Stocks To Own For 2015: Constellation Energy Partners LLC (CEP)
Constellation Energy Partners LLC (CEP) is engaged on the acquisition, development and production of onshore oils and natural gas properties in the United States. All of the Company's proved reserves are located in the Black Warrior Basin in Alabama, the Cherokee Basin in Kansas and Oklahoma, the Woodford Shale in the Arkoma Basin in Oklahoma and the Central Kansas Uplift in Kansas and Nebraska. The Company operates its oil and natural gases properties as one business segment: the exploration, development and production of oil and natural gas. As of December 31, 2011, the Company's total estimated proved reserves were approximately 201.3 billions of cubic feet equivalent (Bcfe), approximately 76% of which were classified as proved developed, and 97% of which are natural gas and 3% of which are oil. As of December 31, 2011, the Company was the operator of approximately 88% of the 2,785 net wells in which the Company owned an interest. In March 2013, it announced sale of its Robinson's Bend Field assets, located in Tuscaloosa County, Alabama.
Black Warrior Basin
The Black Warrior Basin is a coalbed methane basins in the country. The multi-seam vertical wells in the basin range from 500 to 3,700 feet deep, with coal seams averaging a total of 25 to 30 feet of net pay per well. As of December 31, 2011, the Company owned a 100% working interest (an approximate 75% average net revenue interest) in its wells in the Black Warrior Basin, where the Company had 507 producing natural gas wells. The Black Warrior Basin is located in western Tuscaloosa County and Pickens County, Alabama, and encompasses a surface area of approximately 109 square miles. The field has been developed on 80-acre spacing. As of December 31, 2011, the Company was developing its properties in the field on both 40- and 80-acre spacing. The field has seven compressor stations with 800-1,200 horsepower compressors, approximately 170 miles of gas gathering lines (wells to header) and approximately 25 miles of trans! portation lines (header to compressor). In addition, there are approximately 152 miles of water gathering pipes and 28 miles of water transportation pipes. As of December 31, 2011, the Company's estimated proved reserves in the Black Warrior Basin were approximately 84.9 billions of cubic feet equivalent, approximately 88% of which were classified as proved developed, and all of which are natural gas.
Cherokee Basin
The Cherokee Basin is located in the Mid-Continent region in southern Kansas, northern Oklahoma, and western Missouri. It covers approximately 26,500 square miles. The production is natural gas produced from coals and shales. There are multiple producing coal zones in the Cherokee Basin, including the Rowe, Riverton, Weir-Pitt, and Dawson zones. In addition, there are other productive shale zones, as well as conventional sandstone and limestone potential, which can add natural gas and oil production. As of December 31, 2011, the Company owned approximately 2,261 net producing wells in the Cherokee Basin. The Company operates in excess of 20 booster compressors and stations to gets its natural gas to sales points owned by ONEOK Gas Transportation, L.L.C., Scissortail Energy, LLC, Enogex Gas Gathering & Processing, LLC, Enogex Inc., and Southern Star Central Gas Pipeline, Inc. The Company operates a substantial portion of its production in the Cherokee Basin. The Company also own a 50% working interest in wells operated by Bullseye Operating, L.L.C. (Bullseye) and a 50% interest in Bullseye itself. Bullseye operates approximately 500 gross wells in Washington and Nowata Counties in Oklahoma and sells its production through the Cotton Valley producers cooperative, Cotton Valley Compression, L.L.C. The Company's gross working interest in its Cherokee Basin properties is approximately 80%, with its average gross working interest in its operated properties being approximately 100% and its average gross working interest in its non-operated Cherokee Basin properties being a! pproximat! ely 50%. As of December 31, 2011, the Company's estimated proved reserves in the Cherokee Basin were approximately 110.7 billions of cubic feet equivalent, approximately 66% of which were classified as proved developed, and 95% of which were natural gas and 5% of which were oil.
Woodford Shale
The Woodford Shale is located in the Arkoma Basin in southern Oklahoma. As of December 31, 2011, the Company owned 82 well bores, or approximately 9 net producing wells, located in Coal and Hughes counties. This area is gas-rich and is characterized by multiple productive zones. The production of natural gas in the Woodford Shale comes from shale rock that has been stimulated through fracturing jobs after a horizontal well has been drilled. As of December 31, 2011, the Company's 82 wells had an average gross working interest of 11.3% and an average net revenue interest of 9.1%. Approximately 90% of the wells are operated by affiliates of Devon Energy Corporation (Devon) and Newfield Exploration Mid-Continent, Inc. (Newfield), with the remaining wells operated by three additional companies. As of December 31, 2011, the Company's estimated proved reserves in the Woodford Shale were approximately 5.2 billions of cubic feet equivalent.
Central Kansas Uplift
The Central Kansas Uplift is an oil prone region located in Kansas and southern Nebraska. As of December 31, 2011, the Company had a gross acreage position of 4,345 acres, or approximately 1,050 net acres and the Company owned 39 gross wells, or approximately 8 net producing wells. Murfin Drilling Company, Inc., an oil producer in Kansas, operates all of the Company's wells in this region. During the year ended December 31, 2011, the average gross working interest in the wells is approximately 21% and the average net revenue interest is approximately 17%. As of December 31, 2011, the Company's proved reserves in the Central Kansas Uplift were approximately 0.5 billions of cubic feet equivalent, approximately 88%! of which! were classified as proved developed and all of which were oil.
Advisors' Opinion: - [By Rich Smith]
The bulk of these awards came in the form of a single multiple-award, task-order contract to be shared among several energy companies:
Constellation Energy Partners LLC's (NYSEMKT: CEP ) Constellation NewEnergy subsidiary Privately held ECC Renewables LLC Enel Green Power North America, a subsidiary of Italy's Enel SpA LTC Federal LLC Siemens' (NYSE: SI ) Government Technologies unit These five firms are now authorized to bid for individual task orders under an umbrella contract for the procurement of renewable and alternative energy from facilities that are designed, financed, constructed, operated and maintained by private companies on private land under the jurisdiction of the Department of Defense. The ceiling value on this contract is $7 billion, thus accounting for 84% of the value of all Pentagon contracts awarded yesterday.
Hot Managed Healthcare Stocks To Own For 2015: Juno Therapeutics Inc (JUNO)
Juno Therapeutics, Inc. (Juno) is a United States-based clinical-stage biopharmaceutical company. The Company is engaged in developing cell-based cancer immunotherapies based on its chimeric antigen receptor (CAR), and high-affinity T cell receptor (TCR), technologies to genetically engineer T cells to recognize and kill cancer cells. Through genetic engineering, the Company inserts a gene for a particular CAR or TCR construct into the T cell that enables it to better recognize cancer cells. Its CAR technology directs T cells to recognize cancer cells based on the expression of specific proteins located on the cell surface, whereas its TCR technology provides the T cells with a specific T cell receptor to recognize protein fragments derived from either the surface or inside the cell.
To provide treatment, the Company harvests blood cells from a cancer patient, separate the appropriate T cells, activate the cells, insert the gene sequence for the CAR or TCR construct into the cells��Deoxyribonucleic Acid (DNA), and grow these modified T cells to the desired dose level. The modified T cells can then be infused into the patient or frozen and stored for later infusion. Once infused, the T cells are designed to multiply, through a process known as cell expansion, when they encounter the targeted proteins and to kill the targeted cancer cells.
CD19-Directed Product Candidates
The Company�� product candidates, such as JCAR015, JCAR017, and JCAR014, which use CAR technology to target CD19, a protein expressed on the surface of almost all B cell leukemias and lymphomas. The Company has rights to commercialize each of these product candidates across the world. The Company�� JCAR015 is an advanced development product candidate, and it has demonstrated clinically meaningful complete remission rates in adult patients with r/r ALL. JCAR015 uses the CD28 costimulatory domain and CD3 enriched peripheral blood mononuclear cells (PBMC), which requires fewer process steps for! manufacture than its defined cell composition product candidates. JCAR015 is being tested in a Phase I open label clinical trial of patients with r/r ALL for the treatment of refractory chronic lymphocytic leukemia.
JCAR017 also targets CD19, but differs from JCAR015 in several important respects. JCAR017 uses the 4-1BB costimulatory domain and a defined cell composition of CD4+ T cells and CD8+ T cells. JCAR017 is in development for pediatric patients with r/r ALL. JCAR017 is being evaluated in a Phase I/II clinical trial in pediatric r/r ALL.
JCAR014 also targets CD19. JCAR014 uses the 4-1BB costimulatory domain and is composed of CD8+ central memory T cells and CD4+ T cells in a defined ratio. JCAR014 is being evaluated in a Phase I/II trial as a treatment for a number of B cell malignancies in patients relapsed or refractory to standard therapies.
Additional Product Candidates
The Company is exploring the potential of its CAR and TCR technologies against targets that have the potential to treat cancers not targeted by CD19-directed products, in particular, difficult-to-treat solid organ tumors, such as certain breast, lung, and pancreatic cancers, as well as B cell malignancies that do not express CD19. The Company�� CD22 is a cell surface protein widely expressed on B lymphocytes. It is expressed by B cell malignancies, including non-Hodgkin�� lymphoma (NHL), acute lymphoblastic leukemia (ALL), and chronic lymphocytic leukemia (CLL). The Company�� L1CAM, also known as CD171, is a cell-surface adhesion molecule that plays an important role in the development of a normal nervous system. It is overexpressed in neuroblastoma, and there is increasing evidence of aberrant expression in a variety of solid organ tumors, including glioblastoma and lung, pancreatic, and ovarian cancers.
The Company�� MUC-16 is a protein overexpressed in the ovarian cancers, but not on the surface of normal ovary cells. CA-125 is a protein found in the ! blood of ! ovarian cancer patients that results from the cleavage of MUC-16. CA-125 levels in the blood are a common test for ovarian cancer progression because they correlate with cancer progression. Its MUC-16/IL-12 product candidate uses its armored CAR technology. IL-12 is a cytokine that can help overcome the inhibitory effects that the tumor micro-environment can have on T cell activity.
The Company�� ROR-1 is a protein expressed in the formation of embryos, but in normal adult cells its surface expression is predominantly found at low levels on adipocytes, or fat cells, and briefly on precursors to B cells, or pre-B cells, during normal B cell maturation. ROR-1 is overexpressed on a variety of cancers including a subset of non-small cell lung cancer, triple negative breast cancer, pancreatic cancer, and prostate cancer. It is expressed on B cell chronic lymphocytic leukemia and mantle cell lymphoma. The Company�� high-affinity TCR T cell product candidate targets WT-1, an intracellular protein that is overexpressed in a number of cancers, including adult myeloid leukemia, or AML, and non-small cell lung, breast, pancreatic, ovarian, and colorectal cancers.
Advisors' Opinion: - [By John Udovich]
Small cap cancer drug stock Kite Pharma Inc (NASDAQ: KITE) has surged after announcing a�strategic research collaboration and license agreement with Amgen, Inc (NASDAQ: AMGN)�involving Chimeric Antigen Receptors (CAR) ��meaning its worth taking a closer look at the stock, which had an IPO last June,�along with potential peers�Bellicum Pharmaceuticals Inc (NASDAQ: BLCM) and Juno Therapeutics (NASDAQ: JUNO) which are players in the CAR therapies space and had more recent IPOs.
Hot Managed Healthcare Stocks To Own For 2015: Community Trust Bancorp Inc.(CTBI)
Community Trust Bancorp, Inc. operates as the holding company for Community Trust Bank, Inc. that provides various banking products and services. It accepts various deposit product that include checking accounts, regular and term savings accounts and savings certificates, commercial demand deposit accounts, individual retirement accounts and Keogh plans, non interest bearing deposits, NOW accounts, money market deposits, savings accounts, and certificates of deposit and other time deposits. The company?s loan portfolio comprises residential and commercial real estate loans; commercial loans; commercial, construction, mortgage, and personal loans; and lease-financing, lines of credit, revolving lines of credit, term loans, and other specialized loans, including asset-based financing. It also provides full service securities brokerage services; annuity and life insurance products; trust services; debit cards; cash management services to corporate and individual customers; l etters of credit; safe deposit boxes; and funds transfer services. In addition, the company acts as a trustee of personal trusts, an executor of estates, trustee for employee benefit trusts, registrar, transfer agent, paying agent for bond and stock issues; and depositor for securities, as well as provides full service brokerage services. Community Trust operates 80 banking locations in eastern, northeastern, central, and south central Kentucky; southern West Virginia; and northeastern Tennessee, as well as 5 trust offices across Kentucky. The company was founded in 1903 and is headquartered in Pikeville, Kentucky.
Advisors' Opinion: - [By Dividends4Life]
Fair Value: In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description:
1. Avg. High Yield Price
2. 20-Year DCF Price
3. Avg. P/E Price
4. Graham Number
GWW is trading at a premium to all four valuations above. The stock is trading at a 10.0% premium to its calculated fair value of $219.95. GWW did not earn any Stars in this section.
Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description:
1. Free Cash Flow Payout
2. Debt To Total Capital
3. Key Metrics
4. Dividend Growth Rate
5. Years of Div. Growth
6. Rolling 4-yr Div. > 15%
GWW earned three Stars in this section for 1.), 2.) and 3.) above. A Star was earned since the Free Cash Flow payout ratio was less than 60% and there were no negative Free Cash Flows over the last 10 years. The stock earned a Star as a result of its most recent Debt to Total Capital being less than 45%. GWW earned a Star for having an acceptable score in at least two of the four Key Metrics measured.
Rolling 4-yr Div. > 15% means that dividends grew on average in excess of 15% for each consecutive 4 year period over the last 10 years (2003-2006, 2004-2007, 2005-2008, etc.) I consider this a key metric since dividends will double every 5 years if they grow by 15%. The company has paid a cash dividend to shareholders every year since 1965 and has increased its dividend payments for 42 consecutive years.
Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA) or Treasury bond? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked
Hot Managed Healthcare Stocks To Own For 2015: VAALCO Energy Inc (EGY)
VAALCO Energy, Inc. (VAALCO), incorporated in 1985, is an independent energy company principally engaged in the acquisition, exploration, development and production of crude oil and natural gas. VAALCO owns producing properties and conducts exploration activities as operator in Gabon, West Africa, conducts exploration activities as an operator in Angola, West Africa, and has conducted exploration activities as a non-operator in the British North Sea. The Company owns minor interests in production activities as a non-operator in the United States. During the year ended December 31, 2011, the Etame, Avouma, South Tchibala and Ebouri fields produced approximately 8.1 million barrels of oil (2.3 million barrels of oil net to the Company).
Offshore Gabon
The Company�� primary source of revenue is from the Etame Production Sharing Contract related to the Etame Marin block located offshore the Republic of Gabon. VAALCO operates the Etame Marin block on behalf of a consortium of companies. As of December 31, 2010, VAALCO owned a 30.35% interest in the exploration acreage within the Etame Marin block. The Company owns a 28.1% interest in the development areas surrounding the Etame, Avouma, South Tchibala and Ebouri fields, each of which is located on the Etame Marin block. The Company produces from the Etame, Avouma, South Tchibala and Ebouri fields on the block.
Onshore Gabon
The Mutamba Iroru block is ocated onshore near the coast in central Gabon. The Mutamba Iroru block contains an exploration area of approximately 270,000 acres.
Offshore Angola
The Company has 40% working interest in Offshore Angola. The four year primary term with an optional three year extension awards the Company exploration rights to 1.4 million acres offshore central Angola.
Onshore Domestic-Texas
In July 2011, the Company acquired a 480 acre lease in the Granite Wash formation in North Texas. In November 2011, the Company commen! ced drilling a second well on the initial Granite Wash formation lease.
Onshore DomesticMontana
In May 2011, the Company acquired a 70% working interest in approximately 5,200 acres (3,640 net acres) in Sheridan County, Montana in the Middle Bakken formation. In September 2011, it acquired a 65% working interest in approximately 22,000 gross acres covering the Middle Bakken and deeper formations in the East Poplar unit and the Northwest Poplar field in Roosevelt County, Montana.
DomesticOutside Operated
The Company has minor interests in Brazos County, Texas producing from the Buda/Georgetown formations. The Company also owns certain minor non-operated interests in the Ship Shoal area of the Gulf of Mexico and in Pickens County, Alabama.
Advisors' Opinion: - [By Garrett Cook]
Energy services shares fell by 0.12 percent on Friday. Top losers in the sector included Basic Energy Services (NYSE: BAS), down 8.6 percent, and Vaalco Energy (NYSE: EGY), off 5.7 percent.
- [By Nitish]
VAALCO Energy, Inc. (EGY) last month reported net income of $24.7 million or $0.43 per diluted share for the second quarter of 2014 compared to net income of $7.1 million or $0.12 per diluted share for the comparable period in 2013. Second quarter 2014 revenues were $52.1 million compared to$29.1 million in the second quarter of 2013, primarily due to the higher volumes of crude liftings in the second quarter of 2014 as compared to the second quarter of 2013.
- [By Laura Brodbeck]
Thursday
Earnings Expected From: AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO), Kirkland��, Inc (NASDAQ: KIRK), Dollar General Corporation (NYSE: DG), Stein Mart, Inc. (SMRT: NASDAQ), Mattress Firm Holding Corp. (NASDAQ: MRFM), SeaWorld Entertainment (NYSE: SEAS), Vaalco Energy Inc (NYSE: EGY) Economic Releases Expected: Chinese retail sales, French CPI, Brazilian retail sales, US retail sales, Japanese industrial production Friday
